United States of America

United States of America

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.34 (0.30 - 0.38) 2019 Modelled IHME
0.34 (0.30 - 0.38) 2018 Modelled IHME
0.34 (0.30 - 0.39) 2017 Modelled IHME
0.35 (0.31 - 0.39) 2016 Modelled IHME
0.36 (0.32 - 0.41) 2015 Modelled IHME
0.37 (0.33 - 0.42) 2014 Modelled IHME
0.38 (0.33 - 0.42) 2013 Modelled IHME
0.38 (0.34 - 0.43) 2012 Modelled IHME
0.39 (0.34 - 0.44) 2011 Modelled IHME
0.4 (0.35 - 0.45) 2010 Modelled IHME
0.41 (0.36 - 0.46) 2009 Modelled IHME
0.42 (0.37 - 0.47) 2008 Modelled IHME
0.43 (0.37 - 0.48) 2007 Modelled IHME
0.44 (0.38 - 0.49) 2006 Modelled IHME
0.44 (0.39 - 0.50) 2005 Modelled IHME
0.45 (0.39 - 0.51) 2004 Modelled IHME
0.45 (0.40 - 0.51) 2003 Modelled IHME
0.46 (0.40 - 0.52) 2002 Modelled IHME
0.46 (0.40 - 0.52) 2001 Modelled IHME
0.47 (0.41 - 0.52) 2000 Modelled IHME
0.47 (0.41 - 0.53) 1999 Modelled IHME
0.48 (0.42 - 0.54) 1998 Modelled IHME
0.49 (0.42 - 0.55) 1997 Modelled IHME
0.49 (0.43 - 0.56) 1996 Modelled IHME
0.5 (0.43 - 0.56) 1995 Modelled IHME
0.5 (0.44 - 0.57) 1994 Modelled IHME
0.51 (0.44 - 0.58) 1993 Modelled IHME
0.51 (0.45 - 0.58) 1992 Modelled IHME
0.52 (0.45 - 0.59) 1991 Modelled IHME
0.52 (0.45 - 0.59) 1990 Modelled IHME
0.38 (0.29 - 0.49) 1994 Survey/reported Wasley A et al, 2010
0.27 (0.20 - 0.35) 2006 Survey/reported Wasley A et al, 2010
0.3 (0.20 - 0.40) 2012 Survey/reported Roberts H et al, 2016
0.23 (0.18 - 0.28) 2015 Modelled WHO
0.3 (0.20 - 0.30) 2016 Modelled Razavi-Shearer et al, 2018
0.27 (0.24 - 0.30) 2013 Modelled Schweitzer et al, 2015
0.27 (0.24 - 0.30) 2013 Modelled Schweitzer et al, 2015
0.27 (0.24 - 0.30) 2013 Modelled Schweitzer et al, 2015
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.03 (0.02 - 0.04) 2019 Modelled IHME
0.03 (0.02 - 0.04) 2018 Modelled IHME
0.03 (0.02 - 0.04) 2017 Modelled IHME
0.03 (0.02 - 0.04) 2016 Modelled IHME
0.03 (0.02 - 0.04) 2015 Modelled IHME
0.03 (0.02 - 0.04) 2014 Modelled IHME
0.03 (0.03 - 0.04) 2013 Modelled IHME
0.03 (0.03 - 0.04) 2012 Modelled IHME
0.04 (0.03 - 0.04) 2011 Modelled IHME
0.04 (0.03 - 0.04) 2010 Modelled IHME
0.03 (0.03 - 0.04) 2009 Modelled IHME
0.03 (0.03 - 0.04) 2008 Modelled IHME
0.03 (0.02 - 0.04) 2007 Modelled IHME
0.03 (0.02 - 0.04) 2006 Modelled IHME
0.03 (0.02 - 0.04) 2005 Modelled IHME
0.03 (0.02 - 0.04) 2004 Modelled IHME
0.03 (0.02 - 0.04) 2003 Modelled IHME
0.03 (0.03 - 0.04) 2002 Modelled IHME
0.04 (0.03 - 0.05) 2001 Modelled IHME
0.04 (0.03 - 0.05) 2000 Modelled IHME
0.04 (0.03 - 0.05) 1999 Modelled IHME
0.04 (0.03 - 0.05) 1998 Modelled IHME
0.04 (0.03 - 0.06) 1997 Modelled IHME
0.05 (0.04 - 0.06) 1996 Modelled IHME
0.05 (0.04 - 0.07) 1995 Modelled IHME
0.06 (0.04 - 0.08) 1994 Modelled IHME
0.07 (0.05 - 0.09) 1993 Modelled IHME
0.09 (0.07 - 0.11) 1992 Modelled IHME
0.11 (0.08 - 0.13) 1991 Modelled IHME
0.13 (0.10 - 0.16) 1990 Modelled IHME
0.04 (0.03 - 0.05) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
1,317,810 (1,141,740 - 1,502,300) 1990 Modelled IHME
1,324,240 (1,147,580 - 1,507,310) 1991 Modelled IHME
1,329,060 (1,153,480 - 1,508,030) 1992 Modelled IHME
1,332,170 (1,156,540 - 1,512,760) 1993 Modelled IHME
1,333,670 (1,159,600 - 1,507,970) 1994 Modelled IHME
1,333,900 (1,159,670 - 1,504,050) 1995 Modelled IHME
1,331,460 (1,158,810 - 1,498,340) 1996 Modelled IHME
1,326,130 (1,153,930 - 1,494,180) 1997 Modelled IHME
1,319,570 (1,149,530 - 1,484,540) 1998 Modelled IHME
1,313,590 (1,146,460 - 1,476,340) 1999 Modelled IHME
1,310,100 (1,142,500 - 1,472,620) 2000 Modelled IHME
1,309,770 (1,143,240 - 1,473,390) 2001 Modelled IHME
1,311,250 (1,143,560 - 1,474,490) 2002 Modelled IHME
1,313,140 (1,147,220 - 1,476,360) 2003 Modelled IHME
1,313,740 (1,147,160 - 1,476,070) 2004 Modelled IHME
1,311,240 (1,142,650 - 1,473,160) 2005 Modelled IHME
1,302,020 (1,136,430 - 1,465,600) 2006 Modelled IHME
1,285,820 (1,126,040 - 1,446,130) 2007 Modelled IHME
1,265,750 (1,112,440 - 1,424,060) 2008 Modelled IHME
1,245,300 (1,096,350 - 1,399,520) 2009 Modelled IHME
1,228,380 (1,079,050 - 1,381,060) 2010 Modelled IHME
1,216,570 (1,069,660 - 1,365,180) 2011 Modelled IHME
1,207,220 (1,061,900 - 1,352,310) 2012 Modelled IHME
1,197,990 (1,053,860 - 1,340,010) 2013 Modelled IHME
1,186,460 (1,041,800 - 1,328,430) 2014 Modelled IHME
1,169,910 (1,025,460 - 1,309,720) 2015 Modelled IHME
1,136,010 (994,511 - 1,273,420) 2016 Modelled IHME
1,109,810 (970,219 - 1,253,650) 2017 Modelled IHME
1,106,910 (968,416 - 1,250,170) 2018 Modelled IHME
1,108,930 (968,729 - 1,253,410) 2019 Modelled IHME
875,000 (654,000 - 1,033,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.37 (1.18 - 1.58) 2019 Modelled IHME
1.36 (1.18 - 1.55) 2018 Modelled IHME
1.34 (1.17 - 1.52) 2017 Modelled IHME
1.4 (1.25 - 1.57) 2016 Modelled IHME
1.43 (1.28 - 1.59) 2015 Modelled IHME
1.39 (1.25 - 1.54) 2014 Modelled IHME
1.35 (1.22 - 1.50) 2013 Modelled IHME
1.31 (1.18 - 1.45) 2012 Modelled IHME
1.27 (1.15 - 1.40) 2011 Modelled IHME
1.24 (1.12 - 1.36) 2010 Modelled IHME
1.22 (1.11 - 1.34) 2009 Modelled IHME
1.2 (1.10 - 1.32) 2008 Modelled IHME
1.19 (1.08 - 1.29) 2007 Modelled IHME
1.18 (1.08 - 1.28) 2006 Modelled IHME
1.16 (1.06 - 1.26) 2005 Modelled IHME
1.13 (1.03 - 1.23) 2004 Modelled IHME
1.13 (1.03 - 1.23) 2003 Modelled IHME
1.12 (1.02 - 1.22) 2002 Modelled IHME
1.1 (1.01 - 1.20) 2001 Modelled IHME
1.08 (0.99 - 1.18) 2000 Modelled IHME
1.06 (0.97 - 1.15) 1999 Modelled IHME
1.03 (0.95 - 1.12) 1998 Modelled IHME
1.01 (0.93 - 1.10) 1997 Modelled IHME
1 (0.91 - 1.08) 1996 Modelled IHME
0.99 (0.90 - 1.07) 1995 Modelled IHME
0.97 (0.89 - 1.06) 1994 Modelled IHME
0.97 (0.88 - 1.06) 1993 Modelled IHME
0.96 (0.86 - 1.05) 1992 Modelled IHME
0.97 (0.87 - 1.06) 1991 Modelled IHME
0.99 (0.88 - 1.10) 1990 Modelled IHME
0.5 2014 Survey/reported US CDC
0.45 2016 Survey/reported US CDC
0.46 2017 Survey/reported US CDC
0.52 2010 Survey/reported US CDC
0.51 2011 Survey/reported US CDC
0.51 2012 Survey/reported US CDC
0.53 2013 Survey/reported US CDC
0.46 2015 Survey/reported US CDC
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
4,486 (3,874 - 5,178) 2019 Modelled IHME
4,422 (3,862 - 5,064) 2018 Modelled IHME
4,345 (3,813 - 4,935) 2017 Modelled IHME
4,516 (4,023 - 5,073) 2016 Modelled IHME
4,584 (4,107 - 5,100) 2015 Modelled IHME
4,423 (3,984 - 4,917) 2014 Modelled IHME
4,261 (3,856 - 4,728) 2013 Modelled IHME
4,108 (3,718 - 4,543) 2012 Modelled IHME
3,965 (3,595 - 4,371) 2011 Modelled IHME
3,817 (3,459 - 4,201) 2010 Modelled IHME
3,739 (3,397 - 4,099) 2009 Modelled IHME
3,654 (3,327 - 4,001) 2008 Modelled IHME
3,569 (3,252 - 3,893) 2007 Modelled IHME
3,498 (3,202 - 3,815) 2006 Modelled IHME
3,408 (3,118 - 3,714) 2005 Modelled IHME
3,292 (3,017 - 3,587) 2004 Modelled IHME
3,262 (2,985 - 3,558) 2003 Modelled IHME
3,196 (2,930 - 3,479) 2002 Modelled IHME
3,120 (2,858 - 3,393) 2001 Modelled IHME
3,041 (2,791 - 3,302) 2000 Modelled IHME
2,947 (2,705 - 3,193) 1999 Modelled IHME
2,845 (2,611 - 3,087) 1998 Modelled IHME
2,752 (2,520 - 2,989) 1997 Modelled IHME
2,688 (2,461 - 2,917) 1996 Modelled IHME
2,639 (2,413 - 2,869) 1995 Modelled IHME
2,576 (2,351 - 2,803) 1994 Modelled IHME
2,533 (2,299 - 2,770) 1993 Modelled IHME
2,479 (2,241 - 2,724) 1992 Modelled IHME
2,475 (2,228 - 2,727) 1991 Modelled IHME
2,498 (2,240 - 2,778) 1990 Modelled IHME
11,522 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
12 (10 - 14) 2019 Modelled IHME
12 (10 - 14) 2018 Modelled IHME
12 (10 - 14) 2017 Modelled IHME
12 (10 - 14) 2016 Modelled IHME
12 (10 - 14) 2015 Modelled IHME
12 (11 - 14) 2014 Modelled IHME
12 (11 - 14) 2013 Modelled IHME
12 (11 - 14) 2012 Modelled IHME
12 (11 - 14) 2011 Modelled IHME
12 (11 - 14) 2010 Modelled IHME
13 (11 - 14) 2009 Modelled IHME
13 (11 - 14) 2008 Modelled IHME
13 (11 - 14) 2007 Modelled IHME
13 (11 - 15) 2006 Modelled IHME
13 (11 - 15) 2005 Modelled IHME
13 (12 - 15) 2004 Modelled IHME
13 (12 - 15) 2003 Modelled IHME
13 (12 - 15) 2002 Modelled IHME
13 (12 - 15) 2001 Modelled IHME
13 (12 - 15) 2000 Modelled IHME
13 (12 - 14) 1999 Modelled IHME
13 (11 - 14) 1998 Modelled IHME
13 (11 - 14) 1997 Modelled IHME
13 (11 - 14) 1996 Modelled IHME
13 (11 - 14) 1995 Modelled IHME
13 (11 - 14) 1994 Modelled IHME
13 (11 - 14) 1993 Modelled IHME
13 (11 - 15) 1992 Modelled IHME
13 (11 - 15) 1991 Modelled IHME
13 (11 - 15) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
67 2019 Survey/reported WHO/UNICEF
66 2018 Survey/reported WHO/UNICEF
64 2017 Survey/reported WHO/UNICEF
64 2016 Survey/reported WHO/UNICEF
72 2015 Survey/reported WHO/UNICEF
72 2014 Survey/reported WHO/UNICEF
74 2013 Survey/reported WHO/UNICEF
72 2012 Survey/reported WHO/UNICEF
69 2011 Survey/reported WHO/UNICEF
64 2010 Survey/reported WHO/UNICEF
61 2009 Survey/reported WHO/UNICEF
55 2008 Survey/reported WHO/UNICEF
53 2007 Survey/reported WHO/UNICEF
50 2006 Survey/reported WHO/UNICEF
50 2005 Survey/reported WHO/UNICEF
48 2004 Survey/reported WHO/UNICEF
39 2003 Survey/reported WHO/UNICEF
21 2002 Survey/reported WHO/UNICEF
69 2020 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
91 2019 Survey/reported WHO/UNICEF
91 2020 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
30 (11 - 49) 2016 Survey/reported NASEN, 2015; Wejnert C et al, 2016; Des Jarlais D et al , 2013
Technical notes
HBV National Action Plan
Source:
HBV elimination goal
Source:
Year of HBV elimination goal
2030
Source:
HBV testing policy
Pregnant women, Risk-based
Source:
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
1999
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
HCV testing policy
Universal
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.18 (0.95 - 1.45) 2019 Modelled IHME
1.18 (0.96 - 1.45) 2018 Modelled IHME
1.18 (0.96 - 1.45) 2017 Modelled IHME
1.15 (0.94 - 1.41) 2016 Modelled IHME
1.12 (0.91 - 1.38) 2015 Modelled IHME
1.12 (0.91 - 1.37) 2014 Modelled IHME
1.11 (0.90 - 1.36) 2013 Modelled IHME
1.1 (0.90 - 1.36) 2012 Modelled IHME
1.1 (0.89 - 1.36) 2011 Modelled IHME
1.1 (0.89 - 1.36) 2010 Modelled IHME
1.11 (0.90 - 1.37) 2009 Modelled IHME
1.12 (0.90 - 1.38) 2008 Modelled IHME
1.13 (0.91 - 1.40) 2007 Modelled IHME
1.14 (0.92 - 1.41) 2006 Modelled IHME
1.14 (0.92 - 1.42) 2005 Modelled IHME
1.14 (0.92 - 1.42) 2004 Modelled IHME
1.14 (0.92 - 1.41) 2003 Modelled IHME
1.14 (0.92 - 1.41) 2002 Modelled IHME
1.14 (0.92 - 1.41) 2001 Modelled IHME
1.14 (0.92 - 1.41) 2000 Modelled IHME
1.13 (0.91 - 1.40) 1999 Modelled IHME
1.11 (0.89 - 1.38) 1998 Modelled IHME
1.08 (0.87 - 1.34) 1997 Modelled IHME
1.06 (0.85 - 1.31) 1996 Modelled IHME
1.04 (0.83 - 1.29) 1995 Modelled IHME
1.02 (0.82 - 1.27) 1994 Modelled IHME
1.01 (0.81 - 1.26) 1993 Modelled IHME
1 (0.81 - 1.25) 1992 Modelled IHME
0.99 (0.80 - 1.24) 1991 Modelled IHME
0.99 (0.79 - 1.23) 1990 Modelled IHME
1 (0.80 - 1.10) 2016 Survey/reported Hofmeister MG et al, 2019 (Adjusted)
1 (0.80 - 1.20) 2010 Survey/reported Denniston MM et al, 2014 (Unadjusted)
1.3 (1 - 1.50) 2002 Survey/reported Armstrong GL wt al, 2006 (Unadjusted)
0.9 (0.70 - 1.20) 2015 Modelled Blach et al, 2017
0.84 (0.75 - 0.96) 2016 Survey/reported Rosenberg et al, 2018 (Unadjusted)
0.93 2016 Survey/reported Rosenberg et al, 2018 (Adjusted)
1 (0.90 - 1.80) 2014 Modelled Gower et al, 2014
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.49 (0.37 - 0.64) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.7 (1.40 - 2) 2016 Survey/reported Hofmeister MG et al, 2019 (Adjusted)
1.3 (1.20 - 1.50) 2010 Survey/reported Denniston MM et al, 2014 (Unadjusted)
1.6 (1.30 - 1.90) 2002 Survey/reported Armstrong GL wt al, 2006 (Unadjusted)
1.8 (1.50 - 2.30) 1994 Survey/reported Alter MJ et al, 1999 (Unadjusted)
1.9 (1.50 - 2.50) 2002 Survey/reported Ditah et al, 2014
1.3 (0.90 - 1.80) 2006 Survey/reported Ditah et al, 2014
1.3 (1.20 - 2.40) 2014 Modelled Gower et al, 2014
1.48 2019 Modelled Jin et al. 2017
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
4.4 2019 Modelled Jin et al. 2017
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
9.7 (7.10 - 12.60) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
53.1 (38.10 - 68) 2016 Modelled Degenhardt L et al, 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
2,502,880 (2,004,160 - 3,130,610) 1990 Modelled IHME
2,546,430 (2,043,900 - 3,182,130) 1991 Modelled IHME
2,596,220 (2,088,110 - 3,238,600) 1992 Modelled IHME
2,650,820 (2,132,340 - 3,306,200) 1993 Modelled IHME
2,709,170 (2,180,460 - 3,372,500) 1994 Modelled IHME
2,770,670 (2,230,810 - 3,444,260) 1995 Modelled IHME
2,848,100 (2,293,540 - 3,535,790) 1996 Modelled IHME
2,945,160 (2,370,670 - 3,660,720) 1997 Modelled IHME
3,046,070 (2,451,420 - 3,794,290) 1998 Modelled IHME
3,134,450 (2,518,830 - 3,904,060) 1999 Modelled IHME
3,193,420 (2,568,350 - 3,968,570) 2000 Modelled IHME
3,230,980 (2,602,030 - 4,000,380) 2001 Modelled IHME
3,267,410 (2,634,270 - 4,038,940) 2002 Modelled IHME
3,303,160 (2,665,360 - 4,086,760) 2003 Modelled IHME
3,338,110 (2,695,040 - 4,137,130) 2004 Modelled IHME
3,372,040 (2,724,350 - 4,187,150) 2005 Modelled IHME
3,392,560 (2,742,490 - 4,212,400) 2006 Modelled IHME
3,394,700 (2,747,430 - 4,209,860) 2007 Modelled IHME
3,389,100 (2,745,630 - 4,198,660) 2008 Modelled IHME
3,387,400 (2,747,660 - 4,185,320) 2009 Modelled IHME
3,402,520 (2,765,160 - 4,193,890) 2010 Modelled IHME
3,432,790 (2,786,310 - 4,230,320) 2011 Modelled IHME
3,467,850 (2,815,500 - 4,270,910) 2012 Modelled IHME
3,507,740 (2,849,370 - 4,315,400) 2013 Modelled IHME
3,552,530 (2,888,320 - 4,365,520) 2014 Modelled IHME
3,601,660 (2,913,580 - 4,419,880) 2015 Modelled IHME
3,722,760 (3,022,960 - 4,564,600) 2016 Modelled IHME
3,829,820 (3,111,390 - 4,697,660) 2017 Modelled IHME
3,850,280 (3,123,950 - 4,718,760) 2018 Modelled IHME
3,865,100 (3,131,620 - 4,746,640) 2019 Modelled IHME
2,936,000 (2,231,000 - 3,826,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
368,000 (280,000 - 480,000) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
11.9 (10.80 - 13.10) 2019 Modelled IHME
11.8 (10.70 - 13.10) 2018 Modelled IHME
11.7 (10.60 - 12.90) 2017 Modelled IHME
11.73 (10.80 - 12.80) 2016 Modelled IHME
11.4 (10.60 - 12.40) 2015 Modelled IHME
11.1 (10.30 - 12.10) 2014 Modelled IHME
10.9 (10.10 - 11.80) 2013 Modelled IHME
10.7 (9.88 - 11.50) 2012 Modelled IHME
10.4 (9.69 - 11.20) 2011 Modelled IHME
10.1 (9.40 - 10.90) 2010 Modelled IHME
9.99 (9.28 - 10.80) 2009 Modelled IHME
9.77 (9.09 - 10.50) 2008 Modelled IHME
9.54 (8.88 - 10.30) 2007 Modelled IHME
9.4 (8.76 - 10.10) 2006 Modelled IHME
9.24 (8.62 - 9.95) 2005 Modelled IHME
9.01 (8.41 - 9.68) 2004 Modelled IHME
9 (8.41 - 9.66) 2003 Modelled IHME
8.84 (8.27 - 9.48) 2002 Modelled IHME
8.62 (8.08 - 9.25) 2001 Modelled IHME
8.4 (7.87 - 9.01) 2000 Modelled IHME
8.17 (7.63 - 8.78) 1999 Modelled IHME
7.94 (7.39 - 8.53) 1998 Modelled IHME
7.75 (7.23 - 8.33) 1997 Modelled IHME
7.63 (7.10 - 8.20) 1996 Modelled IHME
7.56 (7.03 - 8.13) 1995 Modelled IHME
7.4 (6.87 - 7.95) 1994 Modelled IHME
7.23 (6.70 - 7.80) 1993 Modelled IHME
6.95 (6.41 - 7.53) 1992 Modelled IHME
6.8 (6.24 - 7.43) 1991 Modelled IHME
6.68 (6.07 - 7.37) 1990 Modelled IHME
4.45 2016 Survey/reported US CDC, 2016
4.91 2015 Survey/reported US CDC, 2020
5.01 2014 Survey/reported US CDC, 2019
5.03 2013 Survey/reported US CDC, 2018
4.96 2012 Survey/reported US CDC, 2017
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
39,158 (35,520 - 43,124) 2019 Modelled IHME
38,668 (35,028 - 42,654) 2018 Modelled IHME
38,054 (34,421 - 41,900) 2017 Modelled IHME
37,842 (34,759 - 41,187) 2016 Modelled IHME
36,565 (33,841 - 39,660) 2015 Modelled IHME
35,460 (32,872 - 38,434) 2014 Modelled IHME
34,425 (31,893 - 37,241) 2013 Modelled IHME
33,475 (31,022 - 36,115) 2012 Modelled IHME
32,530 (30,185 - 35,022) 2011 Modelled IHME
31,333 (29,056 - 33,738) 2010 Modelled IHME
30,611 (28,418 - 33,016) 2009 Modelled IHME
29,671 (27,590 - 31,990) 2008 Modelled IHME
28,701 (26,694 - 30,881) 2007 Modelled IHME
27,985 (26,076 - 30,138) 2006 Modelled IHME
27,242 (25,403 - 29,330) 2005 Modelled IHME
26,287 (24,541 - 28,240) 2004 Modelled IHME
26,004 (24,309 - 27,918) 2003 Modelled IHME
25,293 (23,674 - 27,122) 2002 Modelled IHME
24,439 (22,913 - 26,212) 2001 Modelled IHME
23,578 (22,096 - 25,300) 2000 Modelled IHME
22,700 (21,193 - 24,409) 1999 Modelled IHME
21,850 (20,334 - 23,461) 1998 Modelled IHME
21,121 (19,696 - 22,687) 1997 Modelled IHME
20,584 (19,155 - 22,118) 1996 Modelled IHME
20,201 (18,781 - 21,711) 1995 Modelled IHME
19,577 (18,175 - 21,045) 1994 Modelled IHME
18,940 (17,555 - 20,435) 1993 Modelled IHME
18,010 (16,624 - 19,510) 1992 Modelled IHME
17,433 (16,011 - 19,047) 1991 Modelled IHME
16,950 (15,387 - 18,693) 1990 Modelled IHME
21,698 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
39 (35 - 43) 2019 Modelled IHME
39 (35 - 43) 2018 Modelled IHME
39 (35 - 43) 2017 Modelled IHME
40 (36 - 44) 2016 Modelled IHME
41 (37 - 44) 2015 Modelled IHME
41 (37 - 44) 2014 Modelled IHME
41 (37 - 44) 2013 Modelled IHME
41 (37 - 44) 2012 Modelled IHME
40 (37 - 44) 2011 Modelled IHME
40 (37 - 44) 2010 Modelled IHME
40 (37 - 43) 2009 Modelled IHME
40 (37 - 43) 2008 Modelled IHME
40 (37 - 43) 2007 Modelled IHME
40 (37 - 42) 2006 Modelled IHME
39 (36 - 42) 2005 Modelled IHME
39 (36 - 42) 2004 Modelled IHME
39 (36 - 42) 2003 Modelled IHME
39 (36 - 42) 2002 Modelled IHME
39 (36 - 42) 2001 Modelled IHME
39 (36 - 42) 2000 Modelled IHME
39 (36 - 42) 1999 Modelled IHME
39 (36 - 42) 1998 Modelled IHME
39 (36 - 42) 1997 Modelled IHME
39 (36 - 42) 1996 Modelled IHME
39 (35 - 42) 1995 Modelled IHME
38 (35 - 42) 1994 Modelled IHME
38 (35 - 42) 1993 Modelled IHME
38 (35 - 41) 1992 Modelled IHME
38 (35 - 41) 1991 Modelled IHME
38 (34 - 41) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
30 (11 - 49) 2016 Survey/reported NASEN, 2015; Wejnert C et al, 2016; Des Jarlais D et al , 2013
Technical notes
HBV National Action Plan
Source:
HBV elimination goal
Source:
Year of HBV elimination goal
2030
Source:
HBV testing policy
Pregnant women, Risk-based
Source:
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
1999
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
HCV testing policy
Universal
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Prevalence (national)

Modelled

HBV (HBsAg+)
0.34 (%)
2019
(0.3 - 0.38(%))
IHME
HCV (RNA/cAg+)
1.18 (%)
2019
(0.95 - 1.45(%))
IHME

Survey/surveillance

HBV (HBsAg+)
0.3 (%)
2012
(0.2 - 0.4(%))
Roberts H et al, 2016
HCV (anti-HCV)
1.7 (%)
2016
(1.4 - 2(%))
Hofmeister MG et al, 2019 (Adjusted)

Hepatitis related deaths (national)

Modelled

HBV
4,486
2019
(3,874 - 5,178)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
39,158
2019
(35,520 - 43,124)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.03 (%)
2019, latest modelled
(0.02 - 0.04(%))
IHME

Prevalence PWID

HCV
53.10 (%)
2016, latest modelled
(38.10 - 68(%))
Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
69 (%)
2020
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
30
2016
(11 - 49)
NASEN, 2015; Wejnert C et al, 2016; Des Jarlais D et al , 2013
Eligible for HBV generic medicines
Eligible for HCV generic medicines
Download National Hepatitis Elimination Profile (N-HEP)

Latest news

View all

Action plan

View all

Elimination champion

Rachel Gonzalez

Rachel Gonzalez (2021)

“It is revolutionary what the Hepatitis C Innovation Team (HIT) did because you're talking about a federal health care system made up of more than 150 medical centers and 1000 sites of care. How do you move this giant ship? We built a community and said these goals really are aspirational, but we believe in the field teams. We believe in their ability to be creative -- to push innovation. . . If you [only] work in [a] safe space, you’ll never find many of the genuine breakthroughs that came out of HIT.”

group photo with signs
Group photo of Cherokee Nation
group photo
group photo in Birmingham
women in getting tested shirts
Previous Next

News

Action plans

Resources

Programs

Partners